Skip to main content
Top
Published in: Systematic Reviews 1/2017

Open Access 01-12-2017 | Research

Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit

Authors: Jasmin Alloo, Sanya Vallath, Chris Del Mar, Matt Carter, Sarah Thorning, Justin Clark

Published in: Systematic Reviews | Issue 1/2017

Login to get access

Abstract

Background

Cochrane primarily aims to systematically review trials of effectiveness that are important to inform clinical decisions. Editorial groups support authors to achieve high-quality reviews and prioritise review proposals in their clinical domain that are submitted or elicited. Prioritising proposals requires two approaches, identifying (1) clinical practises for which the evidence of effectiveness is uncertain and (2) interventions in which there are trials of effectiveness (especially randomised controlled trials (RCTs)) not systematically reviewed. This study addresses this second approach for the Cochrane Acute Respiratory Infections Group (CARIG) in order to identify RCTs of acute respiratory infections that have not been systematically reviewed.

Methods

We exported, on the 9th of September 2014, and then compared the group’s trials register of RCTs against a list of current Cochrane ARI (systematic) Reviews to identify gaps in topics (the same intervention and health condition) where completed trials have not been systematically reviewed. We assigned a principle intervention and health condition to each of 157 Cochrane reviews (CRs) and 5393 RCTs.

Results

A majority of topics had been systematically reviewed; however, a substantial number (2174 or 41%) of RCTs were not included in any review. The topic that had been systematically reviewed the most was antibiotic vs placebo for pneumonia with 11 CRs and 205 RCTs. The topic that was the subject of most RCTs was vaccination for influenza with 525 RCTs and 6 CRs. Also, 6 CRs had no RCTs (‘empty reviews’).

Conclusions

We identified many RCT topics that have not been systematically reviewed. They need to be addressed in a separate process to establish their priority to clinicians.
Literature
3.
go back to reference Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11(3):404–6.CrossRefPubMed Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11(3):404–6.CrossRefPubMed
4.
go back to reference Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N, Gill CJ. Systematic differences between Cochrane and non-Cochrane meta-analyses on the same topic: a matched pair analysis. PLoS One. 2015;10(12):e0144980.CrossRefPubMedPubMedCentral Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N, Gill CJ. Systematic differences between Cochrane and non-Cochrane meta-analyses on the same topic: a matched pair analysis. PLoS One. 2015;10(12):e0144980.CrossRefPubMedPubMedCentral
6.
go back to reference Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, Perrier L, Hutton B, Moher D, Straus SE. A scoping review of rapid review methods. BMC Med. 2015;13:224.CrossRefPubMedPubMedCentral Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, Perrier L, Hutton B, Moher D, Straus SE. A scoping review of rapid review methods. BMC Med. 2015;13:224.CrossRefPubMedPubMedCentral
8.
go back to reference Synnot A. Stakeholder priorities for research in health communication and participation: findings from the Cochrane consumers and communication priority setting project. Melbourne: Centre for Health Communication and Participation, La Trobe University; 2016. Synnot A. Stakeholder priorities for research in health communication and participation: findings from the Cochrane consumers and communication priority setting project. Melbourne: Centre for Health Communication and Participation, La Trobe University; 2016.
10.
go back to reference Welsh E, Stovold E, Karner C, Cates C. Cochrane Airways Group reviews were prioritized for updating using a pragmatic approach. J Clin Epidemiol. 2015;68(3):341–6.CrossRefPubMed Welsh E, Stovold E, Karner C, Cates C. Cochrane Airways Group reviews were prioritized for updating using a pragmatic approach. J Clin Epidemiol. 2015;68(3):341–6.CrossRefPubMed
12.
go back to reference Glasziou P, Haynes B. The paths from research to improved health outcomes. ACP J Club. 2005;142(2):A8–10.PubMed Glasziou P, Haynes B. The paths from research to improved health outcomes. ACP J Club. 2005;142(2):A8–10.PubMed
13.
go back to reference Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults. Cochrane Database Syst Rev. 2006 19;(2):CD001169. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults. Cochrane Database Syst Rev. 2006 19;(2):CD001169.
15.
go back to reference Alloo J, Vallath S, Del Mar C, Carter M, Thorning S, Clark J. Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit (Data set). In: Gold Coast: Bond University; 2016. Alloo J, Vallath S, Del Mar C, Carter M, Thorning S, Clark J. Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit (Data set). In: Gold Coast: Bond University; 2016.
Metadata
Title
Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit
Authors
Jasmin Alloo
Sanya Vallath
Chris Del Mar
Matt Carter
Sarah Thorning
Justin Clark
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2017
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-017-0472-0

Other articles of this Issue 1/2017

Systematic Reviews 1/2017 Go to the issue